Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical CancerGlobeNewsWire • 09/18/20
Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes WithGlobeNewsWire • 09/17/20
Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel PipelineGlobeNewsWire • 09/17/20
Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical CancerPRNewsWire • 08/26/20
Agenus: Serial Underperformer's Deep I-O Pipeline Approaching Key Inflection PointsSeeking Alpha • 08/20/20
Agenus Inc. (AGEN) CEO Garo Armen on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease SummitPRNewsWire • 07/21/20
With Multiple Late Stage Cancer Therapies, Agenus Inc. Offers The Best Risk/Reward Profile In BiotechnologySeeking Alpha • 07/09/20
Agenus Cell Therapy and Checkpoint Antibody Combinations Show Curative Preclinical Efficacy at AACR 2020PRNewsWire • 06/22/20
Agenus and AgenTus to Participate in a Panel Presentation on Cell Therapy at the Raymond James Virtual Human Health Innovation ConferencePRNewsWire • 06/17/20
Agenus to Present at the Raymond James Virtual Human Health Innovation ConferencePRNewsWire • 06/17/20